On 5–6 May, Basel buzzed with biotech brilliance as Swiss Biotech Days 2025 united over 3,000 innovators and investors from across theglobe.
As a Swiss-headquartered CRO and proud member of the Swiss Biotech Association, Accelsiors was thrilled to dive into this dynamic event, now a cornerstone of the global biotech calendar.
At our booth, we didn’t just showcase our Early Phase Clinical Trials expertise and global capabilities—we brought a taste of Switzerland with our exclusive Accelsiors Swiss chocolate, a sweet highlight for hundreds of visitors. From start-up founders to seasoned researchers, we engaged in vibrant discussions about navigating early-phase trials and accelerating innovation. One memorable moment? A Canadian biotech CEO shared how our adaptive trial designs could shave months off their timeline—a reminder of why we do what we do.
A standout experience was our participation in the KOTRA Partnership Forum, where we connected with pioneering South Korean biotech firms. These cross-continental dialogues sparked ideas for collaborations that could redefine clinical research, aligning with our mission to drive excellence worldwide.
Swiss Biotech Days 2025 was a melting pot of ideas, from AI-driven R&D to sustainable biomanufacturing, with start-ups and mid-sized biotechs leading the charge. The event reaffirmed Switzerland’s role as a biotech powerhouse and Accelsiors’ commitment to fueling its growth.
Thank you to everyone who visited our booth, shared insights, and made this event unforgettable. Inspired by new connections, we’re eager to turn conversations into impactful partnerships. Ready to accelerate your biotech journey? Reach out at [email protected] to explore how Accelsiors can support your next breakthrough.
